Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial (vol 151, pg 106, 2017)

被引:0
|
作者
Mehta, S.
Sastry, B. K. S.
Souza, R.
Torbicki, A.
Ghofrani, H. A.
Channick, R. N.
Delcroix, M.
Pulido, T.
Simonneau, G.
Wlodarczyk, J.
Rubin, L. J.
Jansa, P.
Hunsche, E.
Galie, N.
Perchenet, L.
Sitbon, O.
机构
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:1287 / 1287
页数:1
相关论文
共 50 条
  • [21] EFFECTS OF TADALAFIL ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
    Pepke-Zaba, J.
    Beardsworth, A.
    Chan, M.
    Angalakuditi, M.
    VALUE IN HEALTH, 2009, 12 (07) : A504 - A504
  • [22] Systematic Review of Health-Related Quality of Life in Patients with Pulmonary Arterial Hypertension
    Gu, Shuyan
    Hu, Huimei
    Dong, Hengjin
    PHARMACOECONOMICS, 2016, 34 (08) : 751 - 770
  • [23] SYSTEMATIC REVIEW OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
    Gu, S.
    Hu, H.
    Dong, H.
    VALUE IN HEALTH, 2016, 19 (03) : A118 - A118
  • [24] Predictors of Health-Related Quality of Life in Patients With Idiopathic Pulmonary Arterial Hypertension
    Matura, Lea Ann
    McDonough, Annette
    Carroll, Diane L.
    JOURNAL OF HOSPICE & PALLIATIVE NURSING, 2012, 14 (04) : 283 - 292
  • [25] Systematic Review of Health-Related Quality of Life in Patients with Pulmonary Arterial Hypertension
    Shuyan Gu
    Huimei Hu
    Hengjin Dong
    PharmacoEconomics, 2016, 34 : 751 - 770
  • [26] Effects of tadalafil on health-related quality of life in patients with pulmonary arterial hypertension
    Pepke-Zaba, J.
    Beardsworth, A.
    Chan, M.
    Angalakuditi, M.
    EUROPEAN HEART JOURNAL, 2009, 30 : 442 - 442
  • [27] Determinants of health-related quality of life in pulmonary arterial hypertension
    Matura, L. A.
    Mc Donough, A.
    Carroll, D. L.
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2012, 11 : S82 - S83
  • [28] Health-related Quality of Life and Survival in Pulmonary Arterial Hypertension
    Mathai, Stephen C.
    Suber, Tomeka
    Khair, Rubina M.
    Kolb, Todd M.
    Damico, Rachel L.
    Hassoun, Paul M.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 (01) : 31 - 39
  • [29] Prediction of Health-related Quality of Life and Hospitalization in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry (vol 203, pg 761, 2021)
    Min, J.
    Badesch, D.
    Chakinala, M.
    Elwing, J.
    Frantz, R.
    Horn, E.
    Klinger, J.
    Lammi, M.
    Mazimba, S.
    Sager, J.
    Shlobin, O.
    Simon, M.
    Thenappan, T.
    Grinnan, D.
    Ventetuolo, C.
    Al-Naamani, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 206 (03) : 362 - 363
  • [30] The Effect Of Macitentan On Long-Term Outcomes In Patients With Pulmonary Arterial Hypertension By Who Functional Class: Data From The Randomized Controlled Seraphin Study
    Channick, R. N.
    Delcroix, M.
    Galie, N.
    Ghofrani, H. A.
    Jansa, P.
    Le Brun, F. O.
    Mehta, S.
    Perchenet, L.
    Pulido, T.
    Sastry, B.
    Sitbon, O.
    Souza, R.
    Torbicki, A.
    Rubin, L. J.
    Simonneau, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189